{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Lack of specific treatment or vaccine for COVID-19\",\"Impact\":\"Increase in the number of laboratory-confirmed COVID-19 cases\",\"Mitigation\":\"Investment in research and development for treatment and vaccine\",\"Technologies\":\"Biotechnology, AI for drug discovery, data analytics for epidemiological studies\",\"People\":\"Global population\",\"Owner\":\"Research institutions, pharmaceutical companies\"},{\"Description\":\"Shortcomings of lockdown measures\",\"Impact\":\"Urgent need for countermeasures to reduce effects of the pandemic\",\"Mitigation\":\"Improved and targeted lockdown measures, public health awareness campaigns\",\"Technologies\":\"Data analytics for monitoring and prediction, mobile applications for contact tracing, remote health monitoring systems\",\"People\":\"Global population, public health authorities\",\"Owner\":\"Government, public health organizations\"},{\"Description\":\"Risk of job loss due to lockdown of non-essential organizations\",\"Impact\":\"Billions of people at risk of losing their jobs\",\"Mitigation\":\"Economic support, retraining programs, investment in digital transformation for job creation\",\"Technologies\":\"Digital twin, IoT, AI, cyber-physical systems, everything-as-a-service (XaaS), data analytics, robots and drones\",\"People\":\"Workers, businesses\",\"Owner\":\"Government, private sector\"}]}"}}